XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues        
Total revenues $ 40,348,777 $ 3,907,611 $ 42,968,542 $ 14,366,695
Operating expenses        
Cost of sales and supportive services 4,796,768 0 4,905,863 915,367
Selling, general and administrative 3,870,927 3,392,228 7,046,952 6,558,794
Research and development 2,709,743 2,038,323 5,859,847 6,035,604
Patent expenses 174,203 182,310 356,800 370,226
Total operating expenses 11,551,641 5,612,861 18,169,462 13,879,991
Operating income (loss) 28,797,136 (1,705,250) 24,799,080 486,704
(Loss) gain from change in fair value of warrant liability (1,619,587) 656,523 (1,635,652) 3,792,788
Loss on extinguishment of Term Loan 0 0 (4,981,461) 0
Interest expense 0 (3,971,031) (3,016,817) (7,899,449)
Other income, net 31,931 737,577 444,295 1,473,706
Income (loss) before income taxes 27,209,480 (4,282,181) 15,609,445 (2,146,251)
(Provision) benefit for income taxes (6,319,322) 1,119,689 (3,616,816) 613,536
Net and comprehensive income (loss) $ 20,890,158 $ (3,162,492) $ 11,992,629 $ (1,532,715)
Basic income (loss) per share (in dollars per share) $ 0.26 $ (0.04) $ 0.15 $ (0.02)
Diluted income (loss) per share (in dollars per share) $ 0.26 $ (0.05) $ 0.15 $ (0.06)
Weighted average shares outstanding: basic (in shares) 80,340,695 80,986,524 80,790,400 80,950,124
Weighted average shares outstanding: diluted (in shares) 80,516,863 82,114,661 80,959,812 82,129,601
Product Sales and Supportive Services [Member]        
Revenues        
Total revenues $ 38,624,450 $ 0 $ 38,737,459 $ 7,142,400
Research and Development [Member]        
Revenues        
Total revenues $ 1,724,327 $ 3,907,611 $ 4,231,083 $ 7,224,295